Skip to main content
Premium Trial:

Request an Annual Quote

Australia Invests A$500M in Medical Genomics Research to Improve Patient Care

NEW YORK (GenomeWeb) – The Australian government has announced that it will invest A$500 million (US$372 million) in genomics as part of its 2018-2019 Health Budget.

Known as the Australian Genomics Health Futures Mission, the program is part of a broader A$1.3 billion national Health and Medical Industry Growth Plan aimed at improving health outcomes of more than 200,000 Australians, according to Australia Minister for Health Greg Hunt.

The mission will include a series of studies to tackle rare diseases and cancers, clinical trials to allow patients early access to test drugs, co-investing with philanthropic and business interests, and a community dialogue to understand the privacy, legal, social, and familial impacts of genomic medicine.

The mission's first genomics project — known as Mackenzie's Mission — will use A$20 million for a preconception screening trial for rare and debilitating birth disorders, including spinal muscular atrophy, fragile X syndrome, and cystic fibrosis.

According to Hunt, the government will also use A$240 million to form the Frontier Science program, which will develop new medical ideas, research, devices, and treatments. In addition, it will establish the A$125 million Targeted Translation Research Accelerator to focus on diabetes and cardiac disease.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.